Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes | NEJM

Null

Abstract Background The comparative effectiveness of glucose-lowering medications for use with metformin to maintain target glycated hemoglobin levels in persons with type 2 diabetes is uncertain. Methods In this trial involving participants with type 2 diabetes of less than 10 years’ duration who were receiving metformin and had glycated hemoglobin levels of 6.8 to 8.5%, we compared the eff...

Read Complete Article

Post a Comment

Previous Post Next Post